SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VGNX -- Variagenics, Inc. -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (31)7/25/2001 8:05:04 AM
From: scaram(o)uche  Read Replies (1) | Respond to of 269
 
EXCLUSIVE: Meeting on Proposed Haplotype Mapping Project Tackles
Thorny Questions
By Ken Howard

But Stephens said the meeting validated Genaissance's four-year approach to mapping. "We
turned the question around to not doing a full map of the whole genome but targeting certain
pharmaceutically relevant genes," he said, adding that a public effort could be "complementary"
to Genaissance's work.


genomeweb.com